COMMUNIQUÉS West-GlobeNewswire

WishBone Medical, Inc. acquires Response Ortho
28/11/2018
WARSAW, Ind., Nov. 28, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. announces the acquisition of Response Ortho. Response Ortho has a complete pediatric line of external and internal fixation and deformity correction [...]
Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
28/11/2018
Research partner City of Hope to present initial safety and efficacy Phase 1 data in relapsed or refractory acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE [...]
Minerva Neurosciences Announces New Patent Application for MIN-117 Related to Broad Effect on Pain
28/11/2018
WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Pluristem to Present First Cohort Data from PLX-R18 Hematological Study at American Society of Hematology’s (ASH) Annual Meeting
28/11/2018
Clinical data from the first cohort of Phase I study for the treatment of incomplete hematopoietic recovery following hematopoietic cell transplantation Program was granted an FDA Orphan Drug Designation HAIFA, Israel, [...]
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
28/11/2018
The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world leader in rapid infectious [...]
Diplomat Selects Inovalon’s Specialty Pharmacy Platform
28/11/2018
Nation’s Largest Independent Provider of Specialty Pharmacy Services to Leverage ScriptMed® Enterprise to Support Operations and Improved Patient Care BOWIE, Md., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV [...]
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
28/11/2018
Company anticipates review process could take up to six months FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and [...]
Share Capital and Votes
28/11/2018
November 28, 2018 Announcement no. 24 Share Capital and Votes Pursuant to section 32 of the Danish Capital Markets Act, it is hereby announced, that BioPorto A/S’ total share capital amounts to DKK 165,687,798 divided [...]
Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer
28/11/2018
WP1732 shown to accumulate beneficially in pancreas HOUSTON, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on [...]
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies
28/11/2018
LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today announced plans for [...]
Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
28/11/2018
– AITL patent expands protection for tipifarnib, provides exclusivity in U.S. to 2037 – – Prospective data from AITL and CXCL12+ cohorts in Phase 2 trial of tipifarnib in PTCL upcoming at ASH 2018 – SAN DIEGO, Nov. 28, [...]
Orion Corporation: Managers' transactions - Agendum Oy
28/11/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 28 November 2018 at 14.15 EET Orion Corporation: Managers' transactions - Agendum Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Epistem completes board line up and launches new NGS service
28/11/2018
MANCHESTER, United Kingdom, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Epistem Limited , the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Benjamin Reed [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
28/11/2018
WAYNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down
28/11/2018
VICTORIA, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Dr. Avtar Dhillon, Executive Chairman, has been [...]
Medigus Announces Third Quarter 2018 Financial Results
28/11/2018
OMER, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization [...]
Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018
28/11/2018
-Event on December 2 in San Diego, CA with Slide Webcast- SOUTH SAN FRANCISCO, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced it will provide a program update for [...]
Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc
28/11/2018
Company announcement, Helsinki, 28 November 2018 at 13:30 Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc The Extraordinary General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS: [...]
ChromaDex to Present at the 11th Annual LD Micro Main Event
28/11/2018
LOS ANGELES, Nov. 28, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief Executive Officer, Rob Fried, Co-Founder & Executive Chairman, Frank Jaksch, and Chief Financial Officer, [...]

Pages